News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-19 3:2:13 am Crinetics’ Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-2 Study in Acromegaly Patients GlobeNewsWire
2024-03-12 1:5:0 pm Crinetics Announces Positive Topline Results from Phase 2 Trial of Paltusotine for the Treatment of Carcinoid Syndrome GlobeNewswire
2024-03-11 1:5:0 pm Crinetics Pharmaceuticals Announces March 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
2024-03-01 5:57:53 am Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q4 2023 Earnings Call Transcript Insider Monkey
2024-03-01 2:37:16 am Crinetics Pharmaceuticals Full Year 2023 Earnings: Misses Expectations Simply Wall St.
2024-02-28 1:36:28 pm Crinetics Pharmaceuticals Inc (CRNX) Reports Increased R&D Investment Amidst Net Loss ... GuruFocus.com
2024-02-28 1:5:0 pm Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update GlobeNewswire
2024-02-28 5:0:0 am Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement GlobeNewswire
2024-02-15 12:14:8 am Steven Cohen Adjusts Position in Crinetics Pharmaceuticals Inc GuruFocus.com
   

Please consider a small donation if you think this website provides you with relevant information